HCA Healthcare Inc's stock surged 5.98% during the pre-market session following the release of its fourth-quarter 2025 financial results and 2026 outlook, which exceeded analyst expectations.
The hospital operator reported adjusted earnings of $8.01 per share for the fourth quarter, beating the consensus estimate of $7.46 per share. The company attributed its performance to robust demand for medical care services and higher utilization of government Medicare insurance plans by older adults availing surgical procedures.
Further fueling investor optimism, HCA provided 2026 profit guidance in the range of $29.10 to $31.50 per share, with the midpoint above the average analyst estimate of $29.46 per share. Additionally, the company's board announced a significant return of capital to shareholders by raising the quarterly dividend by 8.3% to 78 cents per share and authorizing an additional $10 billion share repurchase program.